• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

Må bättre, för mindre! Upp till 50% rabatt på hälsoböcker

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Klinisk medicin och internmedicin
    3. Sjukdomar och rubbningar
    4. Onkologi

    Drug Delivery Landscape in Cancer Research

    AvRanjita Shegokar,Yashwant Pathak

    Häftad, Engelska, 2025

    1 773 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Drug Delivery Landscape in Cancer Research examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospects of cancer drug delivery technology, the book examines clinical translation-related knowledge and the development of different organ related cancers. In 22 chapters, it describes current and new drug delivery systems in twenty different cancers and gives insights into drug delivery strategies and tumor microenvironment management in oral and ocular cancers. This book is a timely and valuable resource for health professionals, scientists, researchers, health practitioners, students, and anyone who wants to broaden their knowledge.

    • Contains current studies of the targeted use of drug delivery systems based on the microenvironmental properties of different cancer types
    • Provides essential information on the most recent drug delivery systems available for different cancer types
    • Explains current technology and its applications to drug delivery in cancer
    • Contains contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

    Produktinformation

    • Utgivningsdatum:2025-06-09
    • Mått:191 x 235 x 26 mm
    • Vikt:1 060 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:504
    • Förlag:Elsevier Science
    • ISBN:9780443291685

    Utforska kategorier

    • Onkologi inom Medicin
    • Farmakologi inom Medicin
    • Medicinsk utrustning och medicinska tekniker inom Medicin

    Mer om författaren

    Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)Yashwant Pathak is a Professor at Taneja College of Pharmacy at the University of South Florida, FL, United States. His area of research is nanotechnology, drug delivery systems, and nutraceuticals. He is also an Ad junct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.

    Innehållsförteckning

    • 1. Liver cancer: current and new drug delivery systems2. Pancreatic cancer: current and new drug delivery systems3. Heart cancer: current and new drug delivery systems4. Bone cancer: current and new drug delivery systems5. Spleen cancer: current and new drug delivery systems6. ENT cancer: current and new drug delivery systems7. Brain/CNS cancer: current and new drug delivery systems8. Skin cancer: current and new drug delivery systems9. Lung cancer: current and new drug delivery systems10. Thorax cancer: current and new drug delivery systems11. Thyroid cancer: current and new drug delivery systems12. Kidney-adrenal: current and new drug delivery systems13. Urinary track: current and new drug delivery systems14. Breast: current and new drug delivery systems15. Colorectal: current and new drug delivery systems16. Blood cancer: current and new drug delivery systems17. Prostate cancer: current and new drug delivery systems18. Ovarian cancer: current and new drug delivery systems19. Stomach and intestinal cancer: current and new drug delivery systems20. Plural and peritoneum Cancer: current and new drug delivery systems21. Drug Delivery Strategies and trends in management of tumour microenvironment of oral cancer22. Drug Delivery Strategies and trends in ocular cancer